|
Volumn 59, Issue 3, 2001, Pages 90-94
|
Infections with non-tuberculous mycobacteria and salmonellae in patients with genetic defects in the interleukin-12/interferon-γ-mediated pathway of macrophage activation
a a a |
Author keywords
Cytokines; Genetics; Interferon gamma; Mycobacteria; Receptors; Susceptibility
|
Indexed keywords
ANTIBIOTIC AGENT;
CYTOKINE;
GAMMA INTERFERON;
GAMMA INTERFERON RECEPTOR;
INTERLEUKIN 12;
INTERLEUKIN 12 RECEPTOR;
INTERLEUKIN 12 RECEPTOR BETA1;
INTERLEUKIN 18;
INTERLEUKIN 2;
PROTEIN P35;
RECEPTOR SUBUNIT;
STAT1 PROTEIN;
STAT4 PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA RECEPTOR;
UNCLASSIFIED DRUG;
ANTIGEN SPECIFICITY;
ANTIMICROBIAL THERAPY;
BACTERIAL VIRULENCE;
BCG VACCINATION;
CELLULAR IMMUNITY;
CYTOKINE RELEASE;
DISEASE COURSE;
DISEASE SEVERITY;
EDITORIAL;
ENVIRONMENTAL FACTOR;
GENETIC POLYMORPHISM;
HISTOPATHOLOGY;
HUMAN;
HUMORAL IMMUNITY;
IMMUNE DEFICIENCY;
INFECTION SENSITIVITY;
LEPROMATOUS LEPROSY;
MACROPHAGE ACTIVATION;
MYCOBACTERIOSIS;
MYCOBACTERIUM TUBERCULOSIS;
PROTEIN DEFECT;
RISK FACTOR;
SALMONELLOSIS;
TUBERCULIN TEST;
ADOLESCENT;
ADULT;
AGE DISTRIBUTION;
CAUSALITY;
CHILD;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
INTERFERON TYPE II;
INTERLEUKIN-12;
MACROPHAGE ACTIVATION;
MUTATION;
MYCOBACTERIUM INFECTIONS;
SALMONELLA INFECTIONS;
|
EID: 0034807743
PISSN: 03002977
EISSN: None
Source Type: Journal
DOI: 10.1016/S0300-2977(01)00147-4 Document Type: Editorial |
Times cited : (3)
|
References (14)
|